Goodpasture syndrome: Difference between revisions
3amrbadawy (talk | contribs) (gp clinical) |
3amrbadawy (talk | contribs) (gp workuo) |
||
| Line 16: | Line 16: | ||
==Diagnosis== | ==Diagnosis== | ||
*Pulmonary | |||
**Depends whether pt stable or not | |||
**See [[hemoptysis]] | |||
*Renal: | |||
UA | |||
CBC | |||
Chemistry | |||
Albumin (often reduced in acute glomerulonephritis) | |||
C3, C4, ASO, ANCA | |||
==Management== | ==Management== | ||
Revision as of 03:53, 24 January 2016
Background
- Goodpasture syndrome (60%): diffuse pulmonary hemorrhage + acute glomerulonephritis.
- Goodpasture disease: glomerulonephritis alone (30%,) pulmonary sx alone (10%,)
- Anti-GBM disease is most precise term for both entities.
- Type II hypersensitivty causing linear IG deposition in glomerular and alveolar BM.
- Triggered by:Sepsis, URI, inhalation injury, smoking, pulmonary edema.
Clinical Features
- Constitutional sx prior to pulmonary/renal complications
- Pulmonary
- Cough, dyspnea, chest pain, hemoptysis, respiratory failure or pulmonary hemorrhage
- Renal
Differential Diagnosis
Diagnosis
- Pulmonary
- Depends whether pt stable or not
- See hemoptysis
- Renal:
UA CBC Chemistry Albumin (often reduced in acute glomerulonephritis) C3, C4, ASO, ANCA
Management
- See Hemoptysis
